The IPO is now live — expect pricing and first trade within the next few days. Monitor for final prospectus details on share count and price band. Strong pre-IPO revenue growth (196% YoY) and insider buying signal investor interest, but valuation will determine near-term trading dynamics.
Price Chart
Executive Summary
Alamar Biosciences' IPO registration has become effective, allowing the company to begin selling shares to the public. The offering is expected to price soon, with shares set to trade on Nasdaq under ticker ALMR.
Key Facts
- IPO registration (Form S-1) has become effective as of April 20, 2026
- Company intends to list on Nasdaq under ticker ALMR
- No pricing or share count details disclosed in this filing, but prior S-1 indicated an expected price range between $[●] and $[●] per share
- Underwriters include J.P. Morgan, BofA Securities, and TD Cowen
- Proceeds will be used for R&D, commercial expansion, and general corporate purposes
Financial Impact
Undisclosed amount to be raised; potential market capitalization near $1.5B post-IPO based on market data
Risk Factors
- Pricing may be volatile at debut due to lack of established trading history
- Dilution risk for existing shareholders if offering size is large
- Execution risk in scaling commercial operations post-IPO
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001252 |
| Document: 9999999995-26-001252-index.html | 9999999995-26-001252 |
| Document: 9999999995-26-001252.txt | 9999999995-26-001252 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (+10.83%) |
Oct 5, 2026 21d ago | Press Release | $32.26 | awaiting T+60 | — | $30.39 (−5.80%) |
Sep 24, 2026 4w ago | Press Release | $32.80 | awaiting T+60 | — | $30.39 (−7.35%) |
Sep 1, 2026 7w ago | 8-K | $30.49 | awaiting T+60 | — | $30.39 (−0.33%) |
Aug 10, 2026 11w ago | 8-K | $36.57 | awaiting T+60 | — | $30.39 (−16.90%) |
Jul 13, 2026 15w ago | Press Release | $27.40 $32.26 | ▲ +17.74% | ▲ +13.74% | $30.39 (+10.91%) |
Jul 10, 2026 15w ago | Press Release | $28.42 $38.13 | ▲ +34.17% | ▲ +31.53% | $30.39 (+6.93%) |
May 8, 2026 24w ago | 8-K | $23.96 $27.11 | ▲ +13.15% | ▲ +8.31% | $30.39 (+26.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers